Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|18|15|1754-1778

ISSN： 1389-4501

Source： Current Drug Targets, Vol.18, Iss.15, 2017-10, pp. : 1754-1778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: New Therapetic Approaches in the Management of Ischemia Reperfusion Injury and Cardiometabolic Diseases: Opportunities and Challenges

By  

Current Drug Targets, Vol. 18, Iss. 15, 2017-10 ,pp. : 1687-1688

Bentham Science Publishers

Access to resources Recommend Favorite

Viral targeting of interferon regulatory factor-3 and type I interferon gene transcription

By Fitzgerald Katherine A  

Future Virology, Vol. 1, Iss. 6, 2006-11 ,pp. : 783-793

Future Medicine

Access to resources Recommend Favorite

Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury

By  

Current Drug Targets, Vol. 18, Iss. 15, 2017-10 ,pp. : 1733-1745

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite

Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges

By Hu Erding   Lee Dennis  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 715-736

Informa Healthcare

Access to resources Recommend Favorite